<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04300387</url>
  </required_header>
  <id_info>
    <org_study_id>IWW-0005</org_study_id>
    <nct_id>NCT04300387</nct_id>
  </id_info>
  <brief_title>Chronic Kidney Disease at Northeast Taiwan: Biomarker and Multidisciplinary Care</brief_title>
  <official_title>Biomarker and Multidisciplinary Predialysis Education in Chronic Kidney Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Science and Technology, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <brief_summary>
    <textblock>
      CKD is a global endemic disease with increased comorbidities and mortality. The prevalence
      and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. Early
      diagnosis of disease and proper management remain challenging. The aims of this study are:

        1. Explore risk factors associated with CKD

        2. Establish multidisciplinary care model for CKD patients

        3. Development cost-effective clinical care pathway for CKD

        4. Provide bio-specimen repository for future study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CKD is a global endemic disease with increased comorbidities and mortality. The prevalence
      and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. Early
      diagnosis of disease and proper management remain challenging. The aims of this study are:

        1. Explore risk factors associated with CKD: demographic, social and genetics factors

        2. Establish multidisciplinary care model for CKD patients

        3. Development cost-effective clinical care pathway for CKD

        4. Provide bio-specimen repository for future study: serum, PBMC, urine and stool
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2011</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage (%)</measure>
    <time_frame>through study completion, every 1 year</time_frame>
    <description>percentage of patients with new CKD, starting dialysis treatments, cardiovascular event or mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>difference of US dollars</measure>
    <time_frame>through study completion, every 1 year</time_frame>
    <description>differences of US dollars of medical care (out patients and inpatients service fees) between groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fold changes of proteins</measure>
    <time_frame>through study completion, every 1 year</time_frame>
    <description>change of levels between groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fold changes of microRNA</measure>
    <time_frame>through study completion, every 1 year</time_frame>
    <description>change of levels between groups</description>
  </secondary_outcome>
  <other_outcome>
    <measure>change of taxonomic units abundance of specific microbiota</measure>
    <time_frame>through study completion, every 1 year</time_frame>
    <description>change of levels between groups</description>
  </other_outcome>
  <other_outcome>
    <measure>changes of metabolites</measure>
    <time_frame>through study completion, every 1 year</time_frame>
    <description>change of levels between groups</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">8000</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>customary care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>customary care for CKD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>multidisciplinary care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>multidisciplinary team care for CKD</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>multidisciplinary care</intervention_name>
    <description>multidisciplinary CKD care involving case management nurse, dietitian, social worker, pharmacists.</description>
    <arm_group_label>multidisciplinary care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects visiting outpatient clinics of nephrology of Chang Gung Memorial Hospital

        Exclusion Criteria:

          -  Patient receiving dialysis or transplantation

          -  Unwilling to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>I-Wen Wu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang Gung Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tsang-Tang Hsieh</last_name>
    <phone>+886-2-27135211</phone>
    <phone_ext>3576</phone_ext>
    <email>tth3388@adm.cgmh.org.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Keelung</city>
        <zip>204</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>I-Wen Wu, MD</last_name>
      <phone>+886-2-24313131</phone>
      <phone_ext>3170</phone_ext>
      <email>a22066@adm.cgmh.org.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <results_reference>
    <citation>Wu IW, Wang SY, Hsu KH, Lee CC, Sun CY, Tsai CJ, Wu MS. Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality--a controlled cohort study based on the NKF/DOQI guidelines. Nephrol Dial Transplant. 2009 Nov;24(11):3426-33. doi: 10.1093/ndt/gfp259. Epub 2009 Jun 2.</citation>
    <PMID>19491379</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen SH, Tsai YF, Sun CY, Wu IW, Lee CC, Wu MS. The impact of self-management support on the progression of chronic kidney disease--a prospective randomized controlled trial. Nephrol Dial Transplant. 2011 Nov;26(11):3560-6. doi: 10.1093/ndt/gfr047. Epub 2011 Mar 17.</citation>
    <PMID>21414969</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 30, 2016</study_first_submitted>
  <study_first_submitted_qc>March 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2020</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chang Gung Memorial Hospital</investigator_affiliation>
    <investigator_full_name>I Wen Wu, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>risk factors</keyword>
  <keyword>omics</keyword>
  <keyword>multidisciplinary care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

